Elvitegravir

1. Elvitegravir - CAS 697761-98-1 Catalog number: B0084- 149112 Elvitegravir is an HIV-1 integrase strand transfer inhibitor (INSTI) for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively. Please be kindly noted that our product can only be used for research to orgnizations or companies and we don't cooperate with personal buyers. Category Inhibitor Targets HIV Integrase SARS-CoV-2 Molecular Formula C23H23ClFNO5 Molecular Weight 447.88 Ordering Information Catalo Catalo g g Number Number Siz Siz e e Pric Pric e e Stoc Stoc k k Quantity Quantity In stoc k B0084- 149112 50 mg $198 0 Order Now Bulk Inquiry Chemical Information Category Inhibitor

2. Molecular Formula C23H23ClFNO5 Molecular Weight 447.88 Specification Properties Reference Reading Purity Purity ≥98% Appearance Appearance Off-White to Pale Yellow Solid Synonyms Synonyms GS-9137; GS 9137; GS9137; JTK-303; JTK 303; JTK303; EVG; D06677; D 06677; D-06 677 Clinical Trial Information NCT Number NCT Number Title Title Condition Or Condition Or Disease Disease Phase Phase Start Start Date Date Sponsor Sponsor Status Status NCT00445146 Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection HIV Infections Phase 2 February 2007 Gilead Sciences Completed NCT00708162 Multicenter, Randomized, Double-Blind, Double- Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir HIV Infection Phase 3 July 2008 Gilead Sciences Completed NCT00708162 Multicenter, Randomized, Double-Blind, Double- Dummy, Phase 3 Study of the Safety and Efficacy of HIV Infection Phase 3 July 2008 Gilead Sciences Completed

3. Elvitegravir Versus Raltegravir NCT01923311 Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment- Experienced Pediatric Participants Acquired Immune Deficiency Syndrome (AIDS) Phase 3 August 26, 2013 Gilead Sciences Terminated Preparing Stock Solutions 1 mg 1 mg 5 mg 5 mg 10 mg 10 mg ConcentrationVolumeMass ConcentrationVolumeMass 1 mM 2.2327 mL 11.1637 mL 22.3274 mL 5 mM 0.4465 mL 2.2327 mL 4.4655 mL 10 mM 0.2233 mL 1.1164 mL 2.2327 mL 50 mM 0.0447 mL 0.2233 mL 0.4465 mL https://www.bocsci.com/elvitegravir-cas-697761-98-1-item-149112.html